GlaxoSmithKline (Canada)

A tutorial on pilot studies: the what, why and how

Lehana Thabane, Jinhui Ma, Rong Chu et al. · BMC Medical Research Methodology · 2010 · 3.2K citations · Full text

Education, Learning-by-doing, Phase Iii Trials +21

A tutorial on sensitivity analyses in clinical trials: the what, why, when and how

Lehana Thabane, Lawrence Mbuagbaw, Shiyuan Zhang et al. · BMC Medical Research Methodology · 2013 · 864 citations · Full text

AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity

Arnaud M. Didierlaurent, Sandra Morel, Laurence Lockman et al. · The Journal of Immunology · 2009 · 732 citations · Full text

Adaptive Immune System, Innate Immune System, Immunology +20

Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

François Raffi, Anita Rachlis, Hans‐Jürgen Stellbrink et al. · The Lancet · 2013 · 537 citations

Week Results, Treatment And Prevention, Human Retrovirus +8

Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression

Susan Swindells, Jaime Andrade‐Villanueva, Gary Richmond et al. · New England Journal of Medicine · 2020 · 523 citations · Full text